Established in April 2003, BIONIME is specialized in the business of biotechnology and medical testing. The first product line is the Self Monitoring Blood Glucose (SMBG) System. BIONIME integrates the top-tier expertise in medical science, chemistry, electronics and precision mechanism to commercialize the patented technology of unique test strip structure.

Today, BIONIME operates 4 subsidiaries in major markets, Europe, America, and China. Our products have been highly recognized by outstanding clinical tests and well-known journals internationally and successfully distributed in the worldwide markets. With the support from our customers, we are confident to grow BIONIME the global competitive leadership in the field of SMBG (Self-Monitor Blood Glucose).

Vision

With our “peace of mind“ medical devices, we offer solutions to patients to accurately manage and control their own health.

Philosophy

Better health for more people

Our philosophy is to provide best quality products to people in need and their care givers, so that they can easily manage their daily health. With this idea in mind, Bionime successfully integrated different technologies, combining Swiss designs and made-in-Taiwan quality assurance to continuously provide world class diagnostic solutions to our customers around the world.The unique product design and accurate and precise testing results brings even better user experiences and builds up customer satisfaction and trust, fulfilling better health for more people. Bionime will do its best to implement this philosophy to ensure your health and living quality.

Corporate Milestones

BIONIME together with qualified experts in the field of diabetes have initiated and completed several SMBG patents during the last few years. Nevertheless, innovation and creativity will continue to characterize BIONIME’s efforts in the SMBG field.

July
Launches Rightest CARE App, the blood glucose self-management App in Google Play and App Store.
July
GM700SB Bluetooth glucometer has been first released in Taiwan.
June
Releases new Rightest logo Rightest logo 
Feb
GM700 Pro has won the Taiwan Excellence Award.
Aug
Certified by Brazil's National Health Surveillance Agency and received ANVISA Certificate
Apr
Successfully obtained Good Manufacturing Practices (GMP) Certification from SGS for additional products including Uric acid and Cholesterol Detection detections.
Dec
Received capital injection by private placement of Dongbao Pharmaceutical Co., Ltd.
Apr
Obtained new patent in China is regarding "Insulin measuring pen with biological sensors".
Jan
Established subsidiary in Pingtan, China
Dec
Received new patent in Germany for “Measuring Device for an Analyte”.
Jun
Members of the Diplomatic and Economic Representatives in Taiwan Visit Bionime for Exchange International Business and Bionime’s Competitive Advantages
Jan
GM720 won the Taiwan Excellence Award
Oct
GM720 won the National Industrial Innovation Award
Sep
GD500 won National Invention and Creation Award
Sep
Pass Taiwan GMP certification
Mar
Mylife Unio Won Reddot Design Award
Mar
New Building & Factory completion
Dec
New Product “Mylife Unio” shipped to European Market
Jan
GE Selects Bionime to Launch Innovative Diabetes Solutions
Dec
Bionime acquires the Innovation Award from Taiwan Ministry Economic Affair.
Sep
BIONIME has passed certification of OHSAS18001.
Jul
Acquisition land property for extending operation
Jul
Pass Taiwan AEO Certification
Mar
Strategic global cooperation with GE during term of Licensing Agreement in diabetes technology.
Dec
Become a public company and traded officially as a hi-tech company on the TWSE.
Sep
Granted the highest award of Taipei Biotech competition.
Aug
Approved to apply a high-tech list company by Industrial Development Bureau, Ministry of Economic Affairs.
Feb
Set up Bionime Australia Pty Limited.
Jul
Granted SFDA of RightestGM100, 110.
May
Launch of Rightest GM550 in Europe.
Apr
Pass KGMP audit.
Jan
Listed on Emerging Stock Market (#4737)
Oct
In strategic alliance with Ypsomed, a Switzerland-based solution provider of injection system for diabetes treatment.
Sep
Granted FDA 510(K) of Rightest GM100, 110.
Aug
First shipment of ODM products.
Mar
Launch new Lancing Device to the market.
Feb
Set up BIONIME USA Corporation.
Aug
Passed ISO 13845 and CMDCAS audit.
July
Passed TNO Certification.
Mar
Launch Rightest GM100.
Feb
Set up BIONIME (ShenZhen) Co., Ltd.
Aug
Granted China SFDA of Rightest GM300 Aug.
Jun
Passed Taiwan GMP Certification Jun.
May
Launch Rightest GM300
Apr
Set up BIONIME GmbH Switzerland in Apr.
Jan
Granted FDA 510(K) of Rightest GM300.
Dec
Set up BIONIME INCORPORATED Dec.
Nov
Granted CE Certification and passed ISO13485 Certification.
Oct
The development of the first generation of blood glucose meter was completed.
Apr
BIONIME was founded at Dali City, Taichung County Apr.

Global locations

Bionime Corporation, Headquarters

TEL: +886 4 2369 2388
FAX: +886 4 2261 7586
E-mail: info@bionime.com
Address: No.100, Sec. 2, Daqing St., South Dist., Taichung City 40242, Taiwan (R.O.C.)
Service Hours: Monday ~ Friday 8:30 am - 5:30 pm
Toll-Free: 0800 371 688

Bionime GmbH (Switzerland)

TEL: +41 71 722 9840
FAX: +41 71 722 9843
E-mail: info.ch@bionime.com
Address: Tramstrasse 16, 9442 Berneck, Switzerland

Bionime USA Corporation

TEL: +1 909 781 6969
FAX: +1 909 781 6970
E-mail: info@bionimeusa.com
Address: 1450 E Spruce Street, Bldg. B, Ontario CA 91761-8314 

Bionime (Pingtan) Co., Ltd.

TEL: +86 591 6252 3167
FAX: +86 591 6252 3166
E-mail:  info@bionime.com
Address: Taiwan Pioneer Park, Pingtan Comprehensive Experimental Area, Pingtan County, Fuzhou City, Fujian Province, China

Bionime (Shanghai)

TEL: +86 21 6209 9336
FAX: +86 21 6208 3537
E-mail:  info@bionime.com
Address: Room 501, No. 567, Tian Yao Qiao Road, Xuhui District, Shanghai City, China